626 related articles for article (PubMed ID: 12885487)
1. Non-steroidal anti-inflammatory drugs and molecular carcinogenesis of colorectal carcinomas.
Huls G; Koornstra JJ; Kleibeuker JH
Lancet; 2003 Jul; 362(9379):230-2. PubMed ID: 12885487
[TBL] [Abstract][Full Text] [Related]
2. Chemoprevention of colorectal cancer: systematic review and economic evaluation.
Cooper K; Squires H; Carroll C; Papaioannou D; Booth A; Logan RF; Maguire C; Hind D; Tappenden P
Health Technol Assess; 2010 Jun; 14(32):1-206. PubMed ID: 20594533
[TBL] [Abstract][Full Text] [Related]
3. Use of NSAIDs for the chemoprevention of colorectal cancer.
Herendeen JM; Lindley C
Ann Pharmacother; 2003 Nov; 37(11):1664-74. PubMed ID: 14565811
[TBL] [Abstract][Full Text] [Related]
4. Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues.
Thun MJ; Henley SJ; Patrono C
J Natl Cancer Inst; 2002 Feb; 94(4):252-66. PubMed ID: 11854387
[TBL] [Abstract][Full Text] [Related]
5. Aspirin and other nonsteroidal anti-inflammatory agents in the prevention of colorectal cancer.
Sandler RS
Important Adv Oncol; 1996; ():123-37. PubMed ID: 8791132
[TBL] [Abstract][Full Text] [Related]
6. Non-steroidal anti-inflammatory drugs and selective apoptotic anti-neoplastic drugs in the prevention of colorectal cancer: the role of super aspirins.
Strul H; Arber N
Isr Med Assoc J; 2000 Sep; 2(9):695-702. PubMed ID: 11062772
[TBL] [Abstract][Full Text] [Related]
7. Chemoprevention with low-dose aspirin, mesalazine, or both in patients with familial adenomatous polyposis without previous colectomy (J-FAPP Study IV): a multicentre, double-blind, randomised, two-by-two factorial design trial.
Ishikawa H; Mutoh M; Sato Y; Doyama H; Tajika M; Tanaka S; Horimatsu T; Takeuchi Y; Kashida H; Tashiro J; Ezoe Y; Nakajima T; Ikematsu H; Hori S; Suzuki S; Otani T; Takayama T; Ohda Y; Mure K; Wakabayashi K; Sakai T
Lancet Gastroenterol Hepatol; 2021 Jun; 6(6):474-481. PubMed ID: 33812492
[TBL] [Abstract][Full Text] [Related]
8. Chemoprevention of colorectal cancer.
Gwyn K; Sinicrope FA
Am J Gastroenterol; 2002 Jan; 97(1):13-21. PubMed ID: 11808936
[TBL] [Abstract][Full Text] [Related]
9. Low dose aspirin, COX-inhibition and chemoprevention of colorectal cancer.
Benamouzig R; Uzzan B; Little J; Chaussade S
Curr Top Med Chem; 2005; 5(5):493-503. PubMed ID: 15974944
[TBL] [Abstract][Full Text] [Related]
10. Prevention of gastrointestinal cancer--the potential role of NSAIDs in colorectal cancer.
Luk GD
Schweiz Med Wochenschr; 1996 May; 126(19):801-12. PubMed ID: 8693304
[TBL] [Abstract][Full Text] [Related]
11. Non steroidal anti-inflammatory drugs (NSAID) and Aspirin for preventing colorectal adenomas and carcinomas.
Asano TK; McLeod RS
Cochrane Database Syst Rev; 2004; 2004(2):CD004079. PubMed ID: 15106236
[TBL] [Abstract][Full Text] [Related]
12. Colorectal cancer prevention: is an ounce of prevention worth a pound of cure?
Gill S; Sinicrope FA
Semin Oncol; 2005 Feb; 32(1):24-34. PubMed ID: 15726503
[TBL] [Abstract][Full Text] [Related]
13. Nonsteroidal anti-inflammatory drugs and aspirin for the prevention of colorectal adenomas and cancer: a systematic review.
Asano TK; McLeod RS
Dis Colon Rectum; 2004 May; 47(5):665-73. PubMed ID: 15054679
[TBL] [Abstract][Full Text] [Related]
14. Aspirin and NSAIDs for the prevention of colorectal cancer.
Baron JA
Recent Results Cancer Res; 2009; 181():223-9. PubMed ID: 19213572
[TBL] [Abstract][Full Text] [Related]
15. Nonsteroidal anti-inflammatory drugs, eicosanoids, and colorectal cancer prevention.
DuBois RN; Giardiello FM; Smalley WE
Gastroenterol Clin North Am; 1996 Dec; 25(4):773-91. PubMed ID: 8960892
[TBL] [Abstract][Full Text] [Related]
16. Chemoprevention of colorectal cancer: slow, steady progress.
Burke CA; Bauer WM; Lashner B
Cleve Clin J Med; 2003 Apr; 70(4):346-50. PubMed ID: 12701989
[TBL] [Abstract][Full Text] [Related]
17. [Non-steroidal anti-inflammatory agents for chemoprevention of colorectal polyps: a meta-analysis].
Wang YP; Wang Q; Gan T; Pan T; Yang JL
Zhonghua Nei Ke Za Zhi; 2004 Jan; 43(1):10-2. PubMed ID: 14990012
[TBL] [Abstract][Full Text] [Related]
18. Cyclo-oxygenase inhibition in colorectal adenomas and cancer.
Ricchi P; Pignata S; Iaffaioli RV; Daniele B
J Clin Gastroenterol; 2003 Oct; 37(4):281-7. PubMed ID: 14506383
[TBL] [Abstract][Full Text] [Related]
19. Cyclooxygenase as a target for colorectal cancer chemoprevention.
Moreira L; Castells A
Curr Drug Targets; 2011 Dec; 12(13):1888-94. PubMed ID: 21158711
[TBL] [Abstract][Full Text] [Related]
20. Colorectal cancer and nonsteroidal anti-inflammatory drugs.
Smalley WE; DuBois RN
Adv Pharmacol; 1997; 39():1-20. PubMed ID: 9160111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
